Otsuka Pharmaceutical Co., Ltd.

This study tests a medicated foam (OPA-15406) for children and infants with atopic dermatitis (eczema). About 198 kids will use the foam daily for 4 weeks to see if it clears or nearly clears their skin. The trial is for children with mild to moderate eczema covering 5-40% of the…

This study tests a medicated foam (1% OPA-15406) against a placebo foam in adults with mild-to-moderate atopic dermatitis (eczema). About 156 participants will apply the foam daily for 4 weeks. The goal is to see if the foam can clear or nearly clear skin symptoms like redness an…